APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Selected research

Market Analysis & Forecast

Global Stem Cell Therapy Market Analysis and Forecast 2026-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchStem Cell Therapy Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Stem Cell Therapy Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stem Cell Therapy Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Stem Cell Therapy Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.

The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.

Read the full market overview

Report Includes

This report presents an overview of global market for Stem Cell Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Stem Cell Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Stem Cell Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Stem Cell Therapy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Stem Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Stem Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.

Stem Cell Therapy Segment by Company

Osiris Therapeutics

NuVasive

Chiesi Pharmaceuticals

JCR Pharmaceutical

Pharmicell

Medi-post

Anterogen

Molmed

Takeda (TiGenix)

Stem Cell Therapy Segment by Type

Autologous

Allogeneic

Stem Cell Therapy Segment by Application

Musculoskeletal Disorder

Wounds & Injuries

Cornea

Cardiovascular Diseases

Others

Stem Cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Stem Cell Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cell Therapy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Autologous Major Player Table 3. Allogeneic Major Player Table 4. Global Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Musculoskeletal Disorder Major Player Table 6. Wounds & Injuries Major Player Table 7. Cornea Major Player Table 8. Cardiovascular Diseases Major Player Table 9. Others Major Player Table 10. Stem Cell Therapy Industry Trends Table 11. Stem Cell Therapy Industry Drivers Table 12. Stem Cell Therapy Industry Opportunities and Challenges Table 13. Stem Cell Therapy Industry Restraints Table 14. Global Stem Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Stem Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Stem Cell Therapy Market Share by Region (2021-2026) Table 17. Global Stem Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Stem Cell Therapy Market Share by Region (2027-2032) Table 19. Global Stem Cell Therapy Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Stem Cell Therapy Revenue Market Share by Players (2021-2026) Table 21. Global Stem Cell Therapy Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Stem Cell Therapy Key Players Headquarters & Area Served Table 23. Global Stem Cell Therapy Players, Product Type & Application Table 24. Global Stem Cell Therapy Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Stem Cell Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Stem Cell Therapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Stem Cell Therapy Revenue Market Share by Type (2021-2026) Table 31. Global Stem Cell Therapy Revenue Market Share by Type (2027-2032) Table 32. Global Stem Cell Therapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Stem Cell Therapy Revenue Market Share by Application (2021-2026) Table 36. Global Stem Cell Therapy Revenue Market Share by Application (2027-2032) Table 37. Osiris Therapeutics Company Information Table 38. Osiris Therapeutics Business Overview Table 39. Osiris Therapeutics Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Osiris Therapeutics Stem Cell Therapy Product Portfolio Table 41. Osiris Therapeutics Recent Development Table 42. NuVasive Company Information Table 43. NuVasive Business Overview Table 44. NuVasive Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. NuVasive Stem Cell Therapy Product Portfolio Table 46. NuVasive Recent Development Table 47. Chiesi Pharmaceuticals Company Information Table 48. Chiesi Pharmaceuticals Business Overview Table 49. Chiesi Pharmaceuticals Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Chiesi Pharmaceuticals Stem Cell Therapy Product Portfolio Table 51. Chiesi Pharmaceuticals Recent Development Table 52. JCR Pharmaceutical Company Information Table 53. JCR Pharmaceutical Business Overview Table 54. JCR Pharmaceutical Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. JCR Pharmaceutical Stem Cell Therapy Product Portfolio Table 56. JCR Pharmaceutical Recent Development Table 57. Pharmicell Company Information Table 58. Pharmicell Business Overview Table 59. Pharmicell Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Pharmicell Stem Cell Therapy Product Portfolio Table 61. Pharmicell Recent Development Table 62. Medi-post Company Information Table 63. Medi-post Business Overview Table 64. Medi-post Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Medi-post Stem Cell Therapy Product Portfolio Table 66. Medi-post Recent Development Table 67. Anterogen Company Information Table 68. Anterogen Business Overview Table 69. Anterogen Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Anterogen Stem Cell Therapy Product Portfolio Table 71. Anterogen Recent Development Table 72. Molmed Company Information Table 73. Molmed Business Overview Table 74. Molmed Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Molmed Stem Cell Therapy Product Portfolio Table 76. Molmed Recent Development Table 77. Takeda (TiGenix) Company Information Table 78. Takeda (TiGenix) Business Overview Table 79. Takeda (TiGenix) Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Takeda (TiGenix) Stem Cell Therapy Product Portfolio Table 81. Takeda (TiGenix) Recent Development Table 82. North America Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Stem Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 88. North America Stem Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 89. Europe Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Stem Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 95. Europe Stem Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 96. China Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 97. China Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 98. China Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 99. China Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 101. Asia Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 102. Asia Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 103. Asia Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Stem Cell Therapy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Stem Cell Therapy Revenue by Region (US$ Million) & (2021-2026) Table 106. Asia Stem Cell Therapy Revenue by Region (US$ Million) & (2027-2032) Table 107. SAMEA Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 108. SAMEA Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 109. SAMEA Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 110. SAMEA Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 111. SAMEA Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. SAMEA Stem Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 113. SAMEA Stem Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Stem Cell Therapy Image Figure 2. Global Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stem Cell Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Autologous Image Figure 5. Allogeneic Image Figure 6. Global Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Stem Cell Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 8. Musculoskeletal Disorder Image Figure 9. Wounds & Injuries Image Figure 10. Cornea Image Figure 11. Cardiovascular Diseases Image Figure 12. Others Image Figure 13. Global Stem Cell Therapy Market Size (US$ Million) & (2021-2032) Figure 14. Global Stem Cell Therapy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Stem Cell Therapy Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Stem Cell Therapy Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Stem Cell Therapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Stem Cell Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Stem Cell Therapy Revenue Market Share by Type (2021-2032) Figure 21. Global Stem Cell Therapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Stem Cell Therapy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Stem Cell Therapy Revenue Market Share by Application (2021-2032) Figure 24. North America Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 26. North America Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 27. North America Stem Cell Therapy Revenue Share by Country (2021-2032) Figure 28. United States Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 33. Europe Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 34. Europe Stem Cell Therapy Revenue Share by Country (2021-2032) Figure 35. Germany Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 45. China Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 46. Asia Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 48. Asia Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 49. Asia Stem Cell Therapy Revenue Share by Region (2021-2032) Figure 50. Japan Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 58. SAMEA Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 59. SAMEA Stem Cell Therapy Revenue Share by Country (2021-2032) Figure 60. Brazil Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous
  • Allogeneic
Applications
  • Musculoskeletal Disorder
  • Wounds & Injuries
  • Cornea
  • Cardiovascular Diseases
  • Others
Companies covered
  • Osiris Therapeutics
  • NuVasive
  • Chiesi Pharmaceuticals
  • JCR Pharmaceutical
  • Pharmicell
  • Medi-post
  • Anterogen
  • Molmed
  • Takeda (TiGenix)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Stem Cell Therapy Market by Type
  3. 1.2.1 Global Stem Cell Therapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Autologous
  5. 1.2.3 Allogeneic
  6. 1.3 Stem Cell Therapy Market by Application
  7. 1.3.1 Global Stem Cell Therapy Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Musculoskeletal Disorder
  9. 1.3.3 Wounds & Injuries
  10. 1.3.4 Cornea
  11. 1.3.5 Cardiovascular Diseases
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Stem Cell Therapy Market Dynamics
  1. 2.1 Stem Cell Therapy Industry Trends
  2. 2.2 Stem Cell Therapy Industry Drivers
  3. 2.3 Stem Cell Therapy Industry Opportunities and Challenges
  4. 2.4 Stem Cell Therapy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Stem Cell Therapy Market Perspective (2021-2032)
  2. 3.2 Global Stem Cell Therapy Growth Trends by Region
  3. 3.2.1 Global Stem Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Stem Cell Therapy Market Size by Region (2021-2026)
  5. 3.2.3 Global Stem Cell Therapy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Stem Cell Therapy Revenue by Players
  2. 4.1.1 Global Stem Cell Therapy Revenue by Players (2021-2026)
  3. 4.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Stem Cell Therapy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Stem Cell Therapy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Stem Cell Therapy Key Players Headquarters & Area Served
  7. 4.4 Global Stem Cell Therapy Players, Product Type & Application
  8. 4.5 Global Stem Cell Therapy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Stem Cell Therapy Market CR5 and HHI
  11. 4.6.3 2025 Stem Cell Therapy Tier 1, Tier 2, and Tier 3
5 Stem Cell Therapy Market Size by Type
  1. 5.1 Global Stem Cell Therapy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Stem Cell Therapy Revenue by Type (2021-2032)
  3. 5.3 Global Stem Cell Therapy Revenue Market Share by Type (2021-2032)
6 Stem Cell Therapy Market Size by Application
  1. 6.1 Global Stem Cell Therapy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Stem Cell Therapy Revenue by Application (2021-2032)
  3. 6.3 Global Stem Cell Therapy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Osiris Therapeutics
  2. 7.1.1 Osiris Therapeutics Company Information
  3. 7.1.2 Osiris Therapeutics Business Overview
  4. 7.1.3 Osiris Therapeutics Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Osiris Therapeutics Stem Cell Therapy Product Portfolio
  6. 7.1.5 Osiris Therapeutics Recent Developments
  7. 7.2 NuVasive
  8. 7.2.1 NuVasive Company Information
  9. 7.2.2 NuVasive Business Overview
  10. 7.2.3 NuVasive Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NuVasive Stem Cell Therapy Product Portfolio
  12. 7.2.5 NuVasive Recent Developments
  13. 7.3 Chiesi Pharmaceuticals
  14. 7.3.1 Chiesi Pharmaceuticals Company Information
  15. 7.3.2 Chiesi Pharmaceuticals Business Overview
  16. 7.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Product Portfolio
  18. 7.3.5 Chiesi Pharmaceuticals Recent Developments
  19. 7.4 JCR Pharmaceutical
  20. 7.4.1 JCR Pharmaceutical Company Information
  21. 7.4.2 JCR Pharmaceutical Business Overview
  22. 7.4.3 JCR Pharmaceutical Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 JCR Pharmaceutical Stem Cell Therapy Product Portfolio
  24. 7.4.5 JCR Pharmaceutical Recent Developments
  25. 7.5 Pharmicell
  26. 7.5.1 Pharmicell Company Information
  27. 7.5.2 Pharmicell Business Overview
  28. 7.5.3 Pharmicell Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pharmicell Stem Cell Therapy Product Portfolio
  30. 7.5.5 Pharmicell Recent Developments
  31. 7.6 Medi-post
  32. 7.6.1 Medi-post Company Information
  33. 7.6.2 Medi-post Business Overview
  34. 7.6.3 Medi-post Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Medi-post Stem Cell Therapy Product Portfolio
  36. 7.6.5 Medi-post Recent Developments
  37. 7.7 Anterogen
  38. 7.7.1 Anterogen Company Information
  39. 7.7.2 Anterogen Business Overview
  40. 7.7.3 Anterogen Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Anterogen Stem Cell Therapy Product Portfolio
  42. 7.7.5 Anterogen Recent Developments
  43. 7.8 Molmed
  44. 7.8.1 Molmed Company Information
  45. 7.8.2 Molmed Business Overview
  46. 7.8.3 Molmed Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Molmed Stem Cell Therapy Product Portfolio
  48. 7.8.5 Molmed Recent Developments
  49. 7.9 Takeda (TiGenix)
  50. 7.9.1 Takeda (TiGenix) Company Information
  51. 7.9.2 Takeda (TiGenix) Business Overview
  52. 7.9.3 Takeda (TiGenix) Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Takeda (TiGenix) Stem Cell Therapy Product Portfolio
  54. 7.9.5 Takeda (TiGenix) Recent Developments
8 North America
  1. 8.1 North America Stem Cell Therapy Revenue (2021-2032)
  2. 8.2 North America Stem Cell Therapy Revenue by Type (2021-2032)
  3. 8.2.1 North America Stem Cell Therapy Revenue by Type (2021-2026)
  4. 8.2.2 North America Stem Cell Therapy Revenue by Type (2027-2032)
  5. 8.3 North America Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 8.4 North America Stem Cell Therapy Revenue by Application (2021-2032)
  7. 8.4.1 North America Stem Cell Therapy Revenue by Application (2021-2026)
  8. 8.4.2 North America Stem Cell Therapy Revenue by Application (2027-2032)
  9. 8.5 North America Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 8.6 North America Stem Cell Therapy Revenue by Country
  11. 8.6.1 North America Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Stem Cell Therapy Revenue by Country (2021-2026)
  13. 8.6.3 North America Stem Cell Therapy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Stem Cell Therapy Revenue (2021-2032)
  2. 9.2 Europe Stem Cell Therapy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Stem Cell Therapy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Stem Cell Therapy Revenue by Type (2027-2032)
  5. 9.3 Europe Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Stem Cell Therapy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Stem Cell Therapy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Stem Cell Therapy Revenue by Application (2027-2032)
  9. 9.5 Europe Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Stem Cell Therapy Revenue by Country
  11. 9.6.1 Europe Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Stem Cell Therapy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Stem Cell Therapy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Stem Cell Therapy Revenue (2021-2032)
  2. 10.2 China Stem Cell Therapy Revenue by Type (2021-2032)
  3. 10.2.1 China Stem Cell Therapy Revenue by Type (2021-2026)
  4. 10.2.2 China Stem Cell Therapy Revenue by Type (2027-2032)
  5. 10.3 China Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 10.4 China Stem Cell Therapy Revenue by Application (2021-2032)
  7. 10.4.1 China Stem Cell Therapy Revenue by Application (2021-2026)
  8. 10.4.2 China Stem Cell Therapy Revenue by Application (2027-2032)
  9. 10.5 China Stem Cell Therapy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Stem Cell Therapy Revenue (2021-2032)
  2. 11.2 Asia Stem Cell Therapy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Stem Cell Therapy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Stem Cell Therapy Revenue by Type (2027-2032)
  5. 11.3 Asia Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Stem Cell Therapy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Stem Cell Therapy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Stem Cell Therapy Revenue by Application (2027-2032)
  9. 11.5 Asia Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Stem Cell Therapy Revenue by Country
  11. 11.6.1 Asia Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Stem Cell Therapy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Stem Cell Therapy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Stem Cell Therapy Revenue (2021-2032)
  2. 12.2 SAMEA Stem Cell Therapy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Stem Cell Therapy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Stem Cell Therapy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Stem Cell Therapy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Stem Cell Therapy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Stem Cell Therapy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Stem Cell Therapy Revenue by Country
  11. 12.6.1 SAMEA Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Stem Cell Therapy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Stem Cell Therapy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst